---
name: ประกาศกระทรวงสาธารณสุข เรื่อง ระบุชื่อยาเสพติดให้โทษในประเภท 4 พ.ศ. 2566
date: '2024-01-17'
category: ง พิเศษ
volume: 141
section: 17
page: 13
source: 'https://ratchakitcha.soc.go.th/documents/17029.pdf'
draft: true
---

# ประกาศกระทรวงสาธารณสุข เรื่อง ระบุชื่อยาเสพติดให้โทษในประเภท 4 พ.ศ. 2566

'1>@01>#1/2@$@12B N1APอ 1>&BAPอ0@N2พ!> QหOP#1Q%'1>N.# b พ . 0 . `cdd P 0#?PN'็%@12/ค/1'1?&'1BAPอ0@N2พ!> QหOP#1Q%'1>N.# b !@/'1>//ลห/@00@N2พ!> P 01>&BAPอ Nพ>"อ% Oล>N'ล?P0%O'ล NพAPอ'1>P0%์Q%@1ค/&คB/ํ@?& C Oล0@N2พ!> QหOP#1 Q%'1>N.# b !@/'1>//ลห/@00@N2พ!> QหON'็%R' O /0ค/@/N1?0&1Oอ0Oล>/?'1>2>#$>.@พ อ@0?0อํ@%@!@/ค/@/Q%/@!1@ `b /11ค2อ OหNพ1>1@&??!>QหOQO'1>//ลห/@00@N2พ!> พ . 0 . `cdb Oล>/@!1@ `9 /11ค2อ OหN'1>//ลห/@00@N2พ!> 1?ฐ/%!1?/N@@11>#1/2@$@12B P 0ค/@/NหO%อ&อค>11/@1'้อ?%Oล>'1@&'1@/0@N2พ!> @ออ'1>@0R/O ? !NอR'%?Q Oอ _ '1>@0%?QN1?0/N@ ì '1>@01>#1/2@$@12B N1APอ 1>&BAPอ0@N2พ!> QหOP#1 Q%'1>N.# b พ . 0 . `cdd î Oอ ` '1>@0%?QQหOQO&?ค?&!?QO!N/?%"? @/?%'1>@0Q%1@>@%BN&1@N'็%!O%R' Oอ a QหO0Nล> ( _ ) '1>@01>#1/2@$@12B N1APอ 1>&BAPอ0@N2พ!> QหOP#1Q%'1>N.# b พ . 0 . `cdc ล/?%#?P b !Bล@ค/ พ . 0 . `cdc ( ` ) '1>@01>#1/2@$@12B N1APอ 1>&BAPอ0@N2พ!> QหOP#1Q%'1>N.# b ( &?&#?P ` ) พ . 0 . `cdd ล/?%#?P _e /?%@ค/ พ . 0 . `cdd Oอ b QหO2@1Nค/?#?PQOQ%@1(ล>!0@N2พ!> QหOP#1Q%'1>N.# _ ห1Aอ'1>N.# ` #?P1>&BAPอ Q%&??#O@0'1>@0%?QN'็%0@N2พ!> QหOP#1Q%'1>N.# b !@/'1>//ลห/@00@N2พ!> P 0QหO1//"@ ( _ ) /?!"B#?PN1?0APอN'็%อ0N@อAP%O!N/?Pค121O@#@Nค/?อ0N@N ? 0/?%?&0@N2พ!> QหOP#1 ? ลN@/ ( ` ) อล#์ (salts) อ0@N2พ!> QหOP#1 ? ลN@/ #?Q%?Q R/N/N@>/?ค/@/NO/O%Q ห1Aอ%ํ@R'QONพAPอ@1Q N/O%O!N>/?@11>&Bค/@/NO/O% ห1AอNAPอ%RR/ON'็%@1Nพ@> ห1AอN'็%1?#?P%ํ@R'QONพAPอN'็%2@1ค/&คB/คB.@พQ%@1!1//>Nค1@>ห์ Oล>ค/&คB/คB.@พอ@1!1/2@1N2พ!> Q%1N@@0@PN'็%Nค1APอ/AอOพ#0์!@/ห/@0/N@ O /0 Nค1APอ/AอOพ#0์ Oล>!OอQO!@//?!"B'1>2ค์อNค1APอ/AอOพ#0์%?Q% '1>@0  /?%#?P 26 $?%/@ค/ พ . 0 . `c 66 ล%N@% 01?OO/ 1?ฐ/%!1?/N@@11>#1/2@$@12B หน้า 13 เลม 141 ตอนพิเศษ 17 ง ราชกิจจานุเบกษา 17 มกราคม 2567

&??#O@"'#>@0#>##/2@$@#2B N#AP/ #>&BAP/"@N2!> QหOP#1Q%'#>N # b  . 0 . `cdd %O@ ? & #?P AP/"@N2!> QหOP#1 AP/#@Nค!? NAP/%R _ /@N!>ค O/%R0R # ์ (acetic anhydride) ethanoyl ethanoate ` />?#>%ค%/R# ์ (acetyl chloride) ethanoyl chloride a O/%@ - N//#์Pค#>#?% ( alpha -ergocryptine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-5-(2-methylpropyl)- 2-(propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!NO/%@ - N//#์P ค#>#?% ( alpha - ergocryptine) @PN'็%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!ห!@"/N@ O /" "@ห#A/ @Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%ห!@" "@N2!> b O/%@ - N//#์Pค#>#>%?% ( alpha -ergocryptinine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-5-(2-methylpropyl)- 2-(propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!N O/%@ - N//#์Pค#> #>%?% ( alpha - ergocryptinine) @PN'็%2N/%(2!Q%!O@#?& #?PR O @Q%#>N&?"%"@ !@!  ห!@"/N@ O /""@

%O@ ? & #?P AP/"@N2!> QหOP#1 AP/#@Nค!? NAP/%R ห#A/@ Q %#>N&?"%!O@#?& /?!"B//$#$>N !@!'#>!/%ห!@" "@N2!> c O/%@ - ี%>%/>?P!/>?!@R! ์ (alpha - phenylacetoacetamide ห#A/ APAA) 3-oxo-2-phenylbutanamide #/!#?Q//'!>ค?% R/PN!/#์ (optical isomer) /"@N2!> QหOP#1 ? %N@/ d O/%@ - ี%>%/>?P!/>?P!R%R##%์ ( alpha -phenylacetoacetonitrile ห#A/ APAAN) 3-oxo-2-phenylbutanenitrile #/!#?Q//'!>ค?% R/PN!/#์ (optical isomer) / "@N2!> QหOP#1 ? %N@/ e b - />%>%>P% - N/O% - N%N/#>%RN/#> ? % (4-anilino- N - phenethylpiperidine ห#A/ ANPP) N -phenyl-1-(2- phenylethyl)piperidin -4-amine f # O/%##@%>%> (anthranilic acid) 2-aminobenzoic acid g b - N/? (4-AP) N -phenylpiperidin-4-amine _^ _ - &O/ - b - N/? (1-boc-4-AP) tert -butyl 4-anilinopiperidine-1- carboxylate __ /?%?P!ค%@/?% (elymoclavine) (6a R ,10a R )-7-methyl- 4,6,6a,7,8,10a- hexahydroindolo[4,3- fg ]quinolin- 9-yl methanol #/!#?Q/%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> Q หOP#1 ? %N@/

%O@ ? & #?P AP/"@N2!> QหOP#1 AP/#@Nค!? NAP/%R N/O%O!N/?%?P!ค%@/?% (elymoclavine) @PN'็%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!ห!@"/N@ O /" "@ห#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N!@! '#>!/%ห!@" "@N2!> _` N//#์Pค/#์%?% (ergocornine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2,5- bis (propan-2- yl)-3,6-dioxooctahydro-2 H - oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7-methyl- 4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!N N//#์Pค/#์%?% (ergocornine) @PN'็%2N/%(2!Q%!O@#?& #?PR O @Q%#>N&?"%"@ !@!ห!@"/N@ O /""@ ห#A/@Q%#>N&?"%!O@#?& /?!"B//$#$>N!@! '#>!/%  ห!@""@N2!> _a N//#์Pค/#์%>%?% (ergocorninine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2,5- bis (propan-2- yl)-3,6-dioxooctahydro-2 H - oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7-methyl- 4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/N/O%O!N N//#์Pค/#์%>%?% (ergocorninine) @PN'็%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!ห!@"/N@ O /" "@ห#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%ห!@" "@N2!>

%O@ ? & #?P AP/"@N2!> QหOP#1 AP/#@Nค!? NAP/%R _b N//#์Pค#>2#?% (ergocristine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-5-phenylmethyl-2- (propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!N N//#์Pค#>2#?% (ergocristine) @PN'็%2N/%(2!Q%!O@#?& #?PR O @Q%#>N&?"%"@ !@!ห!@"/N@ O /""@ ห#A/@Q%#>N&?"%!O@#?& /?!"B//$#$>N!@! '#>!/%ห!@" "@N2!> _ c N//#์Pค#>2#>%?% (ergocristinine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-5-phenylmethyl-2- (propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!N N//#์Pค#>2#>%?% (ergocristinine) @PN'็%2N/%(2!Q%!O@#?& #?PR O @Q%#>N&?"%"@ !@!ห!@"/N@ O /""@ ห#A/@Q%#>N&?"%!O@#?& /?!"B//$#$>N!@! '#>!/%ห!@" "@N2!> _d N&!@ - N//#์Pค#>#?% ( beta -ergocryptine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )-5- (butan-2-yl)-10b-hydroxy-2- (propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!N N&!@ - N//#์Pค#>#?% ( beta -ergocryptine) @PN'็%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!  ห!@"/N@ O /"

%O@ ? & #?P AP/"@N2!> QหOP#1 AP/#@Nค!? NAP/%R "@ห#A/@ Q %#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%ห!@" "@N2!> _ e N&!@ - N//#์Pค#>#>%?% ( beta -ergocryptinine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )-5- (butan-2-yl)-10b-hydroxy-2- (propan-2-yl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!N N&!@ - N//#์Pค#>#>%?% ( beta -ergocryptinine) @PN'็%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!ห!@"/N@ O /" "@ห#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%ห!@" "@N2!> _f N//#์PN!##?% (ergometrine) (6a R ,9 R )- N -(( S )-1-hydroxypropan- 2-yl)-7-methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!N N//#์PN!##?% (ergometrine) @PN'็% 2N/%(2!Q%!O@#?& #?PR O @Q%#>N&?"%"@ !@!ห!@"/N@ O /""@ ห#A/@Q%#>N&?"%!O@#?& /?!"B//$#$>N!@! '#>!/%ห!@" "@N2!> _g N//#์PN!##>%?% (ergometrinine) (6a R ,9 S )- N -(( S )-1-hydroxypropan- 2-yl)-7-methyl-4,6,6a,7,8,9- #/!#?Q/%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!>

%O@ ? & #?P AP/"@N2!> QหOP#1 AP/#@Nค!? NAP/%R hexahydroindolo[4,3- fg ]quinoline-9-carboxamide QหOP#1 ? %N@/ N/O%O!N N//#์PN!##>%?% (ergometrinine) @PN'็%2N/%(2!Q% !O@#?& #?PR O @Q%#>N&?"% "@!@!ห!@"/N@ O /" "@ห#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%ห!@" "@N2!> `^ N//#์P?% (ergosine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2-methyl-5-(2- methylpropyl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$์!N@N N/2N#/#์ O%>/?N#/#์Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!NN//#์P ?% (ergosine) @PN'็% 2N/%(2!Q%!O@#?&#?PR O @Q%#>N&?"%"@!@! ห!@"/N@ O /""@ห#A/ @Q%#>N&?"%!O@#?&/?!"B //$#$>N!@!'#>!/% ห!@""@N2!> `_ N//#์P>%?% (ergosinine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2-methyl-5-(2- methylpropyl)-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!N N//#์P>%?% (ergosinine) @PN'็%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!ห!@"/N@ O /" "@ห#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%ห!@" "@N2!>

%O@ ? & #?P AP/"@N2!> QหOP#1 AP/#@Nค!? NAP/%R `` N//#์P!@!?% (ergotamine) (6a R ,9 R )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2-methyl-5- phenylmethyl-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ] pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!NN//#์P!@!?% (ergotamine) @PN'็%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!ห!@"/N@ O /" "@ห#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%ห!@" "@N2!> `a N//#์P!@!>%?% (ergotaminine) (6a R ,9 S )- N -((2 R ,5 S ,10a S ,10b S )- 10b-hydroxy-2-methyl-5- phenylmethyl-3,6- dioxooctahydro-2 H -oxazolo[3,2- a ]pyrrolo[2,1- c ]pyrazin-2-yl)-7- methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#? Q /%B?%$์!N@N N/2N#/#์ O%>/?N#/#์ Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!N N//#์P!@!>%?% (ergotaminine) @PN'็%2N/%(2!Q% !O@#?&#?PR O @Q%#>N&?"% "@!@!ห!@"/N@ O /" "@ห#A/@Q%#>N&?"% !O@#?&/?!"B//$#$>N !@!'#>!/%ห!@" "@N2!> `b N/#>%> ? %R />?N!! (ethylidene diacetate) 1,1-ethanediol diacetate `c R/P@#/% (isosafrole) 5-(prop-1-enyl)- [1,3]benzodioxole `d R%N/#์@R! ์ (lysergamide) (6a R ,9 R )-7-methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxamide #/!#?Q/%B?%$์!N@N N/2N#/#์ O%>/?N#/#์

%O@ ? & #?P AP/"@N2!> QหOP#1 AP/#@Nค!? NAP/%R Q N /"@N2!> QหOP#1 ? %N@/ N/O%O!N R%N/#์@R! ์ (lysergamide) @PN'็%2N/%(2!Q% !O@#?&#?PR O @Q% #>N&?"%"@!@! ห!@"/N@ O /""@ ห#A/ @Q%#>N&?"%!O@#?& /?!"B//$#$>N!@! '#>!/%ห!@" "@N2!> `e # R%N/#์> (lysergic acid) (6a R ,9 R )-7-methyl-4,6,6a,7,8,9- hexahydroindolo[4,3- fg ]quinoline-9-carboxylic acid `f a , b - N/O! ? ? - ` - ? N!#>% R%>N ! (3,4-MDP-2-P methyl glycidate ห#A/ PMK glycidate) methyl 3-(1,3-benzodioxol-5-yl)- 2-methyl-2-oxiranecarboxylate #/!#?Q2N!/#>P/ - R/PN!/#์ (stereoisomers) /"@N2!> QหOP#1 ? %N@/ `g # a , b - N/O! ? ? - ` - ? N!#>%R%> >  (3,4-MDP-2-P methyl glycidic acid ห#A/ PMK glycidic acid) 3-(1,3-benzodioxol-5-yl)-2- methyl-2-oxiranecarboxylic acid #/!#?Q2N!/#>P/ - R/PN!/#์ (stereoisomers) /"@N2!> QหOP#1 ? %N@/ a^ N!#>% O/%@ - ี%>%/>?P!/>?N!! (methyl alpha - phenylacetoacetate ห#A/ MAPA) methyl 3-oxo-2- phenylbutanoate #/!#?Q//'!>ค?% R/PN!/#์ (optical isomer) / "@N2!> QหOP#1 ? %N@/

%O@ ? & #?P AP/"@N2!> QหOP#1 AP/#@Nค!? NAP/%R a_ a , b - N!#>%?%R //?N%>% - ` - P#@P%% (3,4-methylenedioxyphenyl-2- propanone) 1-([1,3]benzodioxol-5-yl)propan- 2-one a` # N/O% - />?#>%O/%##@%>%> ( N -acetylanthranilic acid) N -acetyl-2-aminobenzoic acid aa %/#์N%#@%>% (norfentanyl) N -phenyl- N -piperidin-4- ylpropanamide ab N/O% - N%N/#>% - b - RN/#>P % ( N -phenethyl-4-piperidone ห#A/ NPP) 1-(2-phenylethyl)piperidin-4-one ac _ - N%>% - ` - P#@P%% (1-phenyl-2-propanone) 1-phenylpropan-2-one ad # N%>%/>?!> (phenylacetic acid) 2-phenylacetic acid N/O%O!N# N%>%/>?!>  N'็%2N/%(2!Q% /?!"BO!N%>P%#2 Q%ค/@!NO!O%R!NN>% #O/"%> c !@! ห!@"/N@ O /"/@ห@# ห#A/!@!ห!@" /N@ O /"@#ค/&คB! คB @/@ห@#2?!/์ #/!"@# N%>%/>?!> #?P(2!/"CNQ%(%>! ? ฑ์ /@ห@#O%>(%>! ? ฑ์ /@ห@#2?!/์#?PQO/?!"B O!N%>P%#2 ? %N@/ O%>!O/QO!@! /?!"B'#>2ค์NAP/O!N %>P%#2/@ห@#N#N@%?Q%

%O@ ? & #?P AP/"@N2!> QหOP#1 AP/#@Nค!? NAP/%R ae RN/P#%/% (piperonal) [1,3]benzodioxole-5- carbaldehyde af @#/% (safrole) 5-(prop-2-enyl)- [1,3]benzodioxole "N/O%@#(%>! O@ห%N@" %O@NO@ 2N//ห#A/!?R/OQ% ค#/&ค#/A#/!"@ 2N/%!N@N/A#?P!? @#/% O%>%QO@!?% @A#?P!?@#/% P "!O/!?%@ห#A/ O/ค/@!#>&B/N@N'็% %QO@!?%@A O%>!? /?!"B'#>2ค์NAP/QO '#>P"%์ Q%>@# !@!ห!@"/N@ O /" "@ ห!@"/N@ O /" (%>! ? ฑ์2!B%R# ห!@"/N@ O /"/@ห@# ห!@"/N@ O /" Nค#AP/2O@/@ ห#A/ ห!@"/N@ O /" /?!"B/?%!#@" #?Q%?Q R!N#/!"@@#%O@(N@% %QO@!?%@A#?P!? @#/% @P!O/ O @N%>%@#!@! !@!#@ d^ OหN '#>!/%ห!@" "@N2!> Powered by TCPDF (www.tcpdf.org)
